drugset / Trial / NCT03162588
Multiple Burrhole Therapy With Erythropoietin for Unstable Moyamoya
NaSingle-groupOpen-labelTreatment
Summary
In this study, the investigators aim to evaluate the indirect revascularization outcomes of a new combination therapy of multiple burrhole procedure with promotion of arteriogenesis by intravenous (IV) erythropoietin (EPO) pretreatment on Moyamoya patients with acute neurological presentation, and outline the clinical and vascular factors associated with revascularization through the burrholes.
Timeline
- Start
- 2010-05-01
- Primary completion
- 2016-09-30
- Completion
- 2016-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | epoetin alfa | Protein / enzyme biologic | 40000 iu | Intravenous |